Navigation Links
Brazilian Healthcare Industry Thrives in Favorable Socioeconomic Environment, Finds Frost & Sullivan

BUENOS AIRES, Argentina, Aug. 28, 2012 /PRNewswire/ -- A complex and diverse set of forces such as government investments, consolidation of the middle class, and high disease burden will fortify Brazil's position as a top-rung market in the global healthcare industry. A mesh of socioeconomic and demographic trends create significant opportunities for local and multinational companies in both healthcare and non-healthcare sectors, and will stoke double-digit growth rates by 2015. One of the biggest gainers will be the pharmaceuticals and biotechnology sector, which is expected to be the sixth largest in the world in 2015.

New analysis from Frost & Sullivan (, Healthcare Landscape, Outlook, and Growth Opportunities in Brazil, finds that the market earned revenues of $32.50 billion in 2011 and estimates this to reach $52.30 billion in 2015.

If you are interested in more information on this research, please send an email to Francesca Valente, Corporate Communications, at, with your full name, company name, title, telephone number, company email address, company Web site, city, state and country.

The Sistema Unico de Saude (SUS), Brazil's unified health system, has significantly increased citizens' access to healthcare with its $176 billion budget from the Multiannual Plan.

"The current positive economic scenario and increase in formal employment in Brazil will drive healthcare spending and the expansion of private health insurance industry," said Frost & Sullivan Industry Analyst William Fujioka. "Additionally, the higher prevalence of obesity, diabetes, HIV/AIDS, and cancer will provide opportunities for various healthcare stakeholders."

While the swelling patient pool attracts investors, complex administrative processes hamper investment, procurement, and care. This necessitates expansion and modernization of the healthcare infrastructure in the country, especially in the public system. Currently, the synergistic processes between philanthropic and private institutions are restricted to large hospitals in the South and Southeast regions.

Brazilian hospitals demonstrate a low rate of adoption of new technologies such as magnetic resonance imaging (MRI) and computed tomography (CT), which comprise only 4.1 percent of the total installed base of diagnostic imaging. However, this underserved market enables healthcare companies to offer innovative solutions to consumers, providers, and payers.

"Innovation need not necessarily come from technology leaps," noted Fujioka. "Lower costs, differentiation of post-sales services, and ease to use can also fulfill unmet needs in the market."

These endeavors will go a long way in helping the Brazilian healthcare industry grow faster than the more mature healthcare industries in the United States, Japan, and Europe.

Healthcare Landscape, Outlook, and Growth Opportunities in Brazil is part of the Advanced Medical Technologies Growth Partnership Services program, which also includes research in the following markets: Analysis of the Cardiac Rhythm Device Market in Mexico and the Biologics Market in Brazil. All research services included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.

Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

  • The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
  • The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.

For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

Contact Us:     Start the discussion

Join Us:           Join our community

Subscribe:       Newsletter on "the next big thing"

Register:         Gain access to visionary innovation

Healthcare Landscape, Outlook, and Growth Opportunities in Brazil


Francesca Valente
Corporate Communications – Latin America
P: +54 11 4777 5300
F: +54 11 4777 5300

SOURCE Frost & Sullivan
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Hill-Rom to Participate in the Morgan Stanley Global Healthcare Conference
2. Patient and Family Engagement Key to Improved Healthcare
3. Watson to Present at the Morgan Stanley 2012 Global Healthcare Conference
4. Savient Pharmaceuticals to Present at the Rodman & Renshaw 14th Annual Healthcare Conference
5. Depomed To Present At Stifel Nicolaus 2012 Healthcare Conference
6. Vanda Pharmaceuticals to Participate in Two September Healthcare Investor Conferences
7. Alimera Sciences To Present At 2012 Stifel Nicolaus Healthcare Conference
8. Accuray Incorporateds CEO to Speak at Morgan Stanley Global Healthcare Conference
9. Human Circuit Recognized as an Industry Leader in Commercial Integrator Magazines Business Series as a Top 5 Healthcare Market Media Integrator for 2012
10. Siemens Healthcare Enters into Definitive Agreement to Acquire Penrith Corporation
11. DURECT to Participate in Upcoming Healthcare Conferences
Post Your Comments:
(Date:6/23/2016)... -- Research and Markets has announced the ... (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality (Filler, ... Global Forecast to 2021" report to their offering. ... pharmaceutical excipients market is projected to reach USD 8.1 ... the forecast period 2016 to 2021. ...
(Date:6/23/2016)... June 23, 2016 Capricor ... ), a biotechnology company focused on the discovery, ... that patient enrollment in its ongoing randomized HOPE-Duchenne ... exceeded 50% of its 24-patient target. Capricor expects ... third quarter of 2016, and to report top ...
(Date:6/23/2016)... RIDGE, Ill. and INDIANAPOLIS ... of students receiving a Lilly Diabetes Tomorrow,s Leaders Scholarship ... The 2016 scholarship winners, announced today online at ... to let type 1 diabetes stand in the way ... Diabetes has supported the Foundation,s scholarship program since 2012, ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... ... BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a ... an hour by 2020 and then adjusting it yearly to increase at the same rate ... assure the wage floor does not erode again, and make future increases more predictable. , ...
(Date:6/24/2016)... ... 24, 2016 , ... EB Medicine presented its first-ever “Issue ... conference in Ponte Vedra Beach, FL. The awards honor the outstanding work of ... and Pediatric Emergency Medicine Practice. , “With this award, we recognize the ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Investment Group (TGIG), has initiated cultivation and processing operations at its production facility, ... Pahrump, Nevada. , Puradigm is the manufacturer of a complete system of proactive ...
(Date:6/24/2016)... , ... June 24, 2016 , ... National recruitment firm ... life sciences executive with extensive sequencing and genomics experience, as Vice President of North ... Ms. Hill will be responsible for leading the sales team in the commercialization of ...
(Date:6/24/2016)... ... 2016 , ... Today, MTI-GlobalStem, a provider of optimized transfection ... to transfect cells, announces its launch of the PluriQ™ G9™ Gene Editing System ... is a complete system for culturing and transfecting human pluripotent stem cells for ...
Breaking Medicine News(10 mins):